» Articles » PMID: 25202322

An Investigation into Anti-proliferative Effects of MicroRNAs Encoded by the MiR-106a-363 Cluster on Human Carcinoma Cells and Keratinocytes Using Microarray Profiling of MiRNA Transcriptomes

Overview
Journal Front Genet
Date 2014 Sep 10
PMID 25202322
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Transfection of human oral squamous carcinoma cells (clone E10) with mimics for unexpressed miR-20b or miR-363-5p, encoded by the miR-106a-363 cluster (miR-20b, miR-106a, miR-363-3p, or miR-363-5p), caused 40-50% decrease in proliferation. Transfection with mimics for miR-18a or miR-92a, encoded by the miR-17-92 cluster (all members being expressed in E10 cells), had no effect on proliferation. In contrast, mimic for the sibling miRNA-19a yielded about 20% inhibition of proliferation. To investigate miRNA involvement profiling of miRNA transcriptomes were carried out using deoxyoligonucleotide microarrays. In transfectants for miR-19a, or miR-20b or miR-363-5p most differentially expressed miRNAs exhibited decreased expression, including some miRNAs encoded in paralogous miR-17-92-or miR-106b-25 cluster. Only in cells transfected with miR-19a mimic significantly increased expression of miR-20b observed-about 50-fold as judged by qRT-PCR. Further studies using qRT-PCR showed that transfection of E10 cells with mimic for miRNAs encoded by miR-17-92 - or miR-106a-363 - or the miR-106b-25 cluster confirmed selective effect on expression on sibling miRNAs. We conclude that high levels of miRNAs encoded by the miR-106a-363 cluster may contribute to inhibition of proliferation by decreasing expression of several sibling miRNAs encoded by miR-17-92 or by the miR-106b-25 cluster. The inhibition of proliferation observed in miR-19a-mimic transfectants is likely caused by the miR-19a-dependent increase in the levels of miR-20b and miR-106a. Bioinformatic analysis of differentially expressed miRNAs from miR-106a, miR-20b and miR-363-5p transfectants, but not miR-92a transfectants, yielded significant associations to "Cellular Growth and Proliferation" and "Cell Cycle." Western blotting results showed that levels of affected proteins to differ between transfectants, suggesting that different anti-proliferative mechanisms may operate in these transfectants.

Citing Articles

miRNA Profiles of Canine Intestinal Carcinomas, Lymphomas and Enteritis Analysed by Digital Droplet PCR from FFPE Material.

Kehl A, Valkai M, Van de Weyer A, Brockmann M, Steiger K, Schusser B Vet Sci. 2023; 10(2).

PMID: 36851429 PMC: 9966613. DOI: 10.3390/vetsci10020125.


The Regulation of Lymph Node Pre-Metastatic Niche Formation in Head and Neck Squamous Cell Carcinoma.

Hu C, Huang Q, Sun Q Front Oncol. 2022; 12:852611.

PMID: 35574333 PMC: 9094482. DOI: 10.3389/fonc.2022.852611.


The roles of extracellular vesicles in the development, microenvironment, anticancer drug resistance, and therapy of head and neck squamous cell carcinoma.

Wang X, Guo J, Yu P, Guo L, Mao X, Wang J J Exp Clin Cancer Res. 2021; 40(1):35.

PMID: 33478586 PMC: 7819156. DOI: 10.1186/s13046-021-01840-x.


hsa-miR-20b-5p and hsa-miR-363-3p Affect Expression of and Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro.

Drobna M, Szarzynska B, Jaksik R, Sedek L, Kuchmiy A, Taghon T Cells. 2020; 9(5).

PMID: 32380791 PMC: 7290785. DOI: 10.3390/cells9051137.


MicroRNAs in ovarian follicular atresia and granulosa cell apoptosis.

Zhang J, Xu Y, Liu H, Pan Z Reprod Biol Endocrinol. 2019; 17(1):9.

PMID: 30630485 PMC: 6329178. DOI: 10.1186/s12958-018-0450-y.


References
1.
Avraham R, Yarden Y . Regulation of signalling by microRNAs. Biochem Soc Trans. 2012; 40(1):26-30. PMC: 3621035. DOI: 10.1042/BST20110623. View

2.
Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan M . Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol. 2012; 45(3):513-20. DOI: 10.1016/j.biocel.2012.12.004. View

3.
He L, Thomson J, Hemann M, Hernando-Monge E, Mu D, Goodson S . A microRNA polycistron as a potential human oncogene. Nature. 2005; 435(7043):828-33. PMC: 4599349. DOI: 10.1038/nature03552. View

4.
Van der Auwera I, Limame R, van Dam P, Vermeulen P, Dirix L, Van Laere S . Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer. 2010; 103(4):532-41. PMC: 2939785. DOI: 10.1038/sj.bjc.6605787. View

5.
Ventura A, Young A, Winslow M, Lintault L, Meissner A, Erkeland S . Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell. 2008; 132(5):875-86. PMC: 2323338. DOI: 10.1016/j.cell.2008.02.019. View